PORTAL: Patient-reported Outcomes After Routine Treatment of Atypical Lesions
Clinical trial NCT03070236 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03070236
- Sponsor
- Dana-Farber Cancer Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-01
- Primary completion
- 2019-05-27
- Enrollment
- 912
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.